Internal medicine

Clinical endpoint

ARDS

Dexamethasone

Respiratory distress

Intensive care medicine

Randomized controlled trial

Mechanical ventilation

Lung

Intensive care unit

Intensive care

Anesthesia

Medicine

JAMA

Acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19) is associated with substantial mortality and use of health care resources. Dexamethasone use might attenuate lung injury in these patients.

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19